Novavax to Participate in BofA Securities 2025 Health Care Conference
Novavax (NASDAQ: NVAX) has announced its participation in the upcoming BofA Securities 2025 Health Care Conference in Las Vegas, Nevada.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Novavax (NASDAQ: NVAX) has announced its participation in the upcoming BofA Securities 2025 Health Care Conference in Las Vegas, Nevada. The company will engage in a fireside chat on Wednesday, May 14, 2025, from 3:00 to 3:30 PM PT. Additionally, Novavax will conduct investor meetings during the conference. The fireside chat will be accessible via webcast on the company's investor relations website at ir.novavax.com, with a replay available for 30 days following the event.
Details
News Market Reaction – NVAX
The recorded move for NVAX in the trading session of this news was -1.98%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Details: | ||||
Fireside Chat | ||||
Date: | Wednesday, May 14, 2025 | |||
Time: | 3:00 – 3:30 p.m. Pacific Time (PT) | |||
Location: | ||||
Conference | ||||
Event: | Investor Meetings | |||
Date: | Wednesday, May 14, 2025 | |||
A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, which includes protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company's core expertise in infectious disease and potentially expanding into other disease areas. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
202-709-5563
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-bofa-securities-2025-health-care-conference-302447909.html
SOURCE Novavax, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.